Production lost due to cervical cancer in Poland in 2012
More details
Hide details
Jagiellonian University Medical College / Collegium Medicum Uniwersytetu Jagiellońskiego, Kraków, Poland (Institute of Public Health, Health Economics and Social Security Department / Instytut Zdrowia Publicznego, Zakład Ekonomiki Zdrowia i Zabezpieczenia Społecznego)
Province Sanitary Epidemiological Station of Lesser Poland / Wojewódzka Stacja Sanitarno-Epidemiologiczna w Krakowie, Kraków, Poland
Corresponding author
Katarzyna Dubas-Jakóbczyk   

Jagiellonian University Medical College, Institute of Public Health, Health Economics and Social Security Department, Grzegórzecka 20, 31-531 Kraków, Poland
Med Pr 2016;67(3):289–299
Background: Poland has one of the highest cervical cancer mortality rates in Europe. It is related to the problem of late diagnosis and low attendance rate in screening programs. The objective of the study has been to assess the annual production loss due to the cervical cancer morbidity and mortality in Poland in 2012. The outcomes have been to provide comprehensive information on cervical cancer’s influence on population’s ability to work and its overall economic burden for the society. The study has also provided the methodological framework for disease-related production losses in Polish settings. Material and Methods: The human capital method was used. The production losses were calculated in both monetary and quantitative terms (working days lost) due to 4 following reasons: 1) temporary disability to work, 2) permanent disability, 3) informal care, and 4) mortality. Results: Cervical cancer resulted in approx. 702 964 working days lost in 2012 due to absence at work for both patients and care givers and a total number of 957 678 working days lost due to patients’ mortality. The total value of production lost was assessed at 111.4 million euros. More than 66% of this value was attributed to women’s mortality. Conclusions: The calculation of production lost due to cervical cancer burden provides strong evidence to support adequate health promotion and disease prevention actions. Actions promoting cervical cancer screening should be intensified including workplace health promotion activities. Med Pr 2016;67(3):289–299